Seeking Alpha

Abbott Labs (ABT) completes the separation of AbbVie (ABBV), its R&D-based pharmaceuticals...

Abbott Labs (ABT) completes the separation of AbbVie (ABBV), its R&D-based pharmaceuticals business that will start trading on the NYSE today. Wells Fargo maintains an "Outperform" rating on Abbott's shares, citing the company's above-average growth outlook and opportunities to significantly increase its margin. Wells Fargo sets Abbott a price target of $33-$34; its shares are $32.25 premarket.(PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)